title: Cholesterol-lowering medications reduce the risk of age-related maculopathy progression.
authors.forename: C A
authors.initials: CA
authors.lastname: McCarty
authors.forename: B N
authors.initials: BN
authors.lastname: Mukesh
authors.forename: R H
authors.initials: RH
authors.lastname: Guymer
authors.forename: P N
authors.initials: PN
authors.lastname: Baird
authors.forename: H R
authors.initials: HR
authors.lastname: Taylor
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000453:epidemiology* / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D014739:Victoria / Q000453:epidemiology
chemical_list: D000924:Anticholesteremic Agents